Per the deal, Google will pay $7.35 per share in cash. With the announcement of the acquisition, Fitbit’s stock spiked 17 percent, CNBC reports. Additionally, Alphabet’s stock was up 0.6 percent. Fitbit expects the transaction to close in 2020, subject to customary closing conditions, including the approval of the company’s stockholders and regulatory approvals.
Over concerns with patient privacy, Fitbit said that consumers’ health and wellness data will not be used for Google ads.
Google hopes to advance its wearables division with the acquisition.
“By working closely with Fitbit’s team of experts, and bringing together the best AI, software and hardware, we can help spur innovation in wearables and build products to benefit even more people around the world,” Google’s hardware chief Rick Osterloh said in a blog post, according to CNBC. “Google also remains committed to Wear OS and our ecosystem partners, and we plan to work closely with Fitbit to combine the best of our respective smartwatch and fitness tracker platforms.”
More articles on health IT:
Emory receives $10M investment in center for innovative, affordable medicine
U of South Florida, Microsoft unveil 1st Medical School of Innovation
How Penn Medicine is analyzing data to improve patient experience
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
